Targeted Therapies

Targeted therapies are medical treatments that selectively target specific molecules or pathways involved in disease progression, offering more precise and effective interventions compared to conventional therapies. Unlike broad-spectrum treatments that may affect both healthy and diseased cells, targeted therapies aim to inhibit or block specific molecular targets associated with disease pathogenesis. These therapies are often based on genetic or molecular characteristics of tumors or other diseases, allowing for personalized treatment approaches. Targeted therapies have revolutionized the treatment of various cancers, autoimmune disorders, and genetic conditions, offering improved outcomes and reduced side effects compared to traditional treatments. They represent a paradigm shift towards precision medicine and personalized healthcare, emphasizing individualized treatment strategies based on molecular insights.

    Related Conference of Targeted Therapies

    January 29-30, 2026

    19th World Drug Delivery Summit

    Paris, France
    February 10-11, 2026

    40th World Congress on Pharmacology and Therapeutics

    Barcelona, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    March 24-25, 2026

    11th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France

    Targeted Therapies Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in